| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 ABCA4 MCM9 NAIP MFN2 INO80 ENPP4 NUDT9 DNAH8 MFN1 TBCC VCP DNAH11 | 1.53e-05 | 839 | 76 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 ABCA4 MCM9 NAIP MFN2 INO80 ENPP4 NUDT9 DNAH8 MFN1 TBCC VCP DNAH11 | 1.54e-05 | 840 | 76 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 ABCA4 MCM9 NAIP MFN2 INO80 ENPP4 NUDT9 DNAH8 MFN1 TBCC VCP DNAH11 | 1.54e-05 | 840 | 76 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.43e-04 | 32 | 76 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | TAP complex binding | 5.06e-04 | 9 | 76 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 5.06e-04 | 9 | 76 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 6.31e-04 | 10 | 76 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 6.31e-04 | 10 | 76 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 6.31e-04 | 10 | 76 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 6.89e-04 | 775 | 76 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 9.21e-04 | 12 | 76 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.40e-03 | 321 | 76 | 6 | GO:0031267 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.41e-03 | 58 | 76 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.44e-03 | 441 | 76 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 1.66e-03 | 16 | 76 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.87e-03 | 17 | 76 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 1.87e-03 | 17 | 76 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.10e-03 | 18 | 76 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | GTPase binding | 2.49e-03 | 360 | 76 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.60e-03 | 20 | 76 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 3.74e-03 | 24 | 76 | 2 | GO:0017075 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 1.34e-05 | 2 | 76 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 2.12e-05 | 15 | 76 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane potential | 2.60e-05 | 16 | 76 | 3 | GO:0010918 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 8.00e-05 | 4 | 76 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane potential | 1.04e-04 | 25 | 76 | 3 | GO:0045838 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 1.47e-04 | 28 | 76 | 3 | GO:0032253 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 7.76e-05 | 23 | 76 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.71e-04 | 7 | 76 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 5.72e-04 | 185 | 76 | 5 | GO:0101002 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 5.76e-04 | 10 | 76 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | cell cortex region | 5.87e-04 | 45 | 76 | 3 | GO:0099738 | |
| Domain | DUF1041 | 6.18e-07 | 5 | 75 | 3 | SM01145 | |
| Domain | DUF1041 | 2.15e-06 | 7 | 75 | 3 | PF06292 | |
| Domain | Munc13_1 | 2.15e-06 | 7 | 75 | 3 | IPR014770 | |
| Domain | CAPS_dom | 2.15e-06 | 7 | 75 | 3 | IPR010439 | |
| Domain | MHD1 | 2.15e-06 | 7 | 75 | 3 | PS51258 | |
| Domain | Mitofusin_fam | 1.59e-05 | 2 | 75 | 2 | IPR027094 | |
| Domain | Fzo_mitofusin | 1.59e-05 | 2 | 75 | 2 | PF04799 | |
| Domain | Fzo/mitofusin_HR2 | 1.59e-05 | 2 | 75 | 2 | IPR006884 | |
| Domain | AAA+_ATPase | 2.46e-05 | 144 | 75 | 6 | IPR003593 | |
| Domain | AAA | 2.46e-05 | 144 | 75 | 6 | SM00382 | |
| Domain | Unc-13 | 4.76e-05 | 3 | 75 | 2 | IPR027080 | |
| Domain | CEBP_ZZ | 9.50e-05 | 4 | 75 | 2 | IPR032296 | |
| Domain | CEBP_ZZ | 9.50e-05 | 4 | 75 | 2 | PF16366 | |
| Domain | RRM_7 | 9.50e-05 | 4 | 75 | 2 | PF16367 | |
| Domain | NACHT | 1.04e-04 | 23 | 75 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 1.04e-04 | 23 | 75 | 3 | IPR007111 | |
| Domain | Munc13_dom-2 | 1.58e-04 | 5 | 75 | 2 | IPR014772 | |
| Domain | Membr_traf_MHD | 1.58e-04 | 5 | 75 | 2 | PF10540 | |
| Domain | MHD2 | 1.58e-04 | 5 | 75 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 1.58e-04 | 5 | 75 | 2 | IPR019558 | |
| Domain | DMAP_binding | 1.58e-04 | 5 | 75 | 2 | PF06464 | |
| Domain | MHC_I_a_C | 2.36e-04 | 6 | 75 | 2 | IPR010579 | |
| Domain | DMAP1-bd | 2.36e-04 | 6 | 75 | 2 | IPR010506 | |
| Domain | MHC_I_C | 2.36e-04 | 6 | 75 | 2 | PF06623 | |
| Domain | DMAP_binding | 2.36e-04 | 6 | 75 | 2 | SM01137 | |
| Domain | DHC_N1 | 4.39e-04 | 8 | 75 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 4.39e-04 | 8 | 75 | 2 | IPR013594 | |
| Domain | P-loop_NTPase | ABCA4 CIITA MCM9 NAIP MFN2 INO80 DNAH8 MFN1 VCP DNAH11 NLRP5 | 5.44e-04 | 848 | 75 | 11 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 1.40e-03 | 14 | 75 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.40e-03 | 14 | 75 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.40e-03 | 14 | 75 | 2 | IPR013602 | |
| Domain | G_DYNAMIN_dom | 1.40e-03 | 14 | 75 | 2 | IPR030381 | |
| Domain | DHC_N2 | 1.40e-03 | 14 | 75 | 2 | PF08393 | |
| Domain | MT | 1.40e-03 | 14 | 75 | 2 | PF12777 | |
| Domain | AAA_8 | 1.40e-03 | 14 | 75 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.40e-03 | 14 | 75 | 2 | IPR011704 | |
| Domain | G_DYNAMIN_2 | 1.40e-03 | 14 | 75 | 2 | PS51718 | |
| Domain | AAA_5 | 1.40e-03 | 14 | 75 | 2 | PF07728 | |
| Domain | DHC_fam | 1.62e-03 | 15 | 75 | 2 | IPR026983 | |
| Domain | Dynamin_GTPase | 1.62e-03 | 15 | 75 | 2 | IPR001401 | |
| Domain | Dynamin_N | 1.62e-03 | 15 | 75 | 2 | PF00350 | |
| Domain | Dynamin_SF | 1.62e-03 | 15 | 75 | 2 | IPR022812 | |
| Domain | Dynein_heavy_dom | 1.62e-03 | 15 | 75 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.62e-03 | 15 | 75 | 2 | PF03028 | |
| Domain | C2 | 1.91e-03 | 131 | 75 | 4 | PF00168 | |
| Domain | C2 | 2.25e-03 | 137 | 75 | 4 | SM00239 | |
| Domain | C2 | 2.56e-03 | 142 | 75 | 4 | PS50004 | |
| Domain | - | 2.93e-03 | 746 | 75 | 9 | 3.40.50.300 | |
| Domain | MHC_I | 3.18e-03 | 21 | 75 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 3.18e-03 | 21 | 75 | 2 | IPR001039 | |
| Domain | Actinin_actin-bd_CS | 3.81e-03 | 23 | 75 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 3.81e-03 | 23 | 75 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.81e-03 | 23 | 75 | 2 | PS00019 | |
| Domain | C2_dom | 4.29e-03 | 164 | 75 | 4 | IPR000008 | |
| Domain | AMP-binding | 6.44e-03 | 30 | 75 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 6.44e-03 | 30 | 75 | 2 | IPR000873 | |
| Domain | Alkaline_phosphatase_core | 6.86e-03 | 31 | 75 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 6.86e-03 | 31 | 75 | 2 | IPR017849 | |
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 23498974 | ||
| Pubmed | Metabolic control of adult neural stem cell self-renewal by the mitochondrial protease YME1L. | 1.00e-07 | 5 | 76 | 3 | 35172139 | |
| Pubmed | Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. | 1.00e-07 | 5 | 76 | 3 | 21173115 | |
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 1.00e-07 | 5 | 76 | 3 | 33139401 | |
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 2.00e-07 | 6 | 76 | 3 | 28635948 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 5.57e-07 | 8 | 76 | 3 | 25609709 | |
| Pubmed | An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. | 8.34e-07 | 9 | 76 | 3 | 22084437 | |
| Pubmed | Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases. | 8.34e-07 | 9 | 76 | 3 | 17088432 | |
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 18292501 | ||
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 1.19e-06 | 10 | 76 | 3 | 21040848 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 1.63e-06 | 11 | 76 | 3 | 25374362 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | UNC13B FLNA DCAF13 IPO9 TEX101 ZBTB10 BEND3 TSEN54 SSR1 NKAPL | 2.00e-06 | 670 | 76 | 10 | 22990118 |
| Pubmed | Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. | 4.71e-06 | 2 | 76 | 2 | 24074867 | |
| Pubmed | Mfn2 is critical for brown adipose tissue thermogenic function. | 4.71e-06 | 2 | 76 | 2 | 28348166 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30690319 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31431479 | ||
| Pubmed | Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model. | 4.71e-06 | 2 | 76 | 2 | 30882371 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34600274 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29212658 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12137943 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17296794 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12070347 | ||
| Pubmed | Mitofusin 1 is required for oocyte growth and communication with follicular somatic cells. | 4.71e-06 | 2 | 76 | 2 | 32281181 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12871971 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17561838 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23070049 | ||
| Pubmed | MFN1 and MFN2 Are Dispensable for Sperm Development and Functions in Mice. | 4.71e-06 | 2 | 76 | 2 | 34948301 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30873819 | ||
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 4.71e-06 | 2 | 76 | 2 | 28489077 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33674260 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 4.71e-06 | 2 | 76 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 4.71e-06 | 2 | 76 | 2 | 22066784 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22511781 | ||
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 4.71e-06 | 2 | 76 | 2 | 32187536 | |
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 4.71e-06 | 2 | 76 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 4.71e-06 | 2 | 76 | 2 | 17267576 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22814762 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19052620 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 4.71e-06 | 2 | 76 | 2 | 28426965 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29661855 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27404125 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35613050 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 4.71e-06 | 2 | 76 | 2 | 30816091 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 37220142 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30936207 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30260752 | ||
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 4.71e-06 | 2 | 76 | 2 | 19558619 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 18701688 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 4.71e-06 | 2 | 76 | 2 | 31851910 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21839087 | ||
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 4.71e-06 | 2 | 76 | 2 | 11832228 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22777004 | ||
| Pubmed | Structural basis of mitochondrial tethering by mitofusin complexes. | 4.71e-06 | 2 | 76 | 2 | 15297672 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 4.71e-06 | 2 | 76 | 2 | 23229896 | |
| Pubmed | Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. | 4.71e-06 | 2 | 76 | 2 | 12759376 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11792326 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11950885 | ||
| Pubmed | MFN2 Plays a Distinct Role from MFN1 in Regulating Spermatogonial Differentiation. | 4.71e-06 | 2 | 76 | 2 | 32330448 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11181170 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24710686 | ||
| Pubmed | A nucleotide deletion in exon 4 is responsible for an HLA-A null allele (A*0105N). | 4.71e-06 | 2 | 76 | 2 | 10519371 | |
| Pubmed | Evaluation of the role of mitofusin-1 and mitofusin-2 in periodontal disease. | 4.71e-06 | 2 | 76 | 2 | 37436713 | |
| Pubmed | Distribution and apoptotic function of outer membrane proteins depend on mitochondrial fusion. | 4.71e-06 | 2 | 76 | 2 | 24813948 | |
| Pubmed | Programme of self-reactive innate-like T cell-mediated cancer immunity. | 5.50e-06 | 16 | 76 | 3 | 35444279 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | OMA1 FLNA DCAF13 IPO9 TMTC3 HLA-A COPB1 MFN2 PLEC JMJD1C MFN1 VCP | 1.12e-05 | 1203 | 76 | 12 | 29180619 |
| Pubmed | 1.25e-05 | 493 | 76 | 8 | 15368895 | ||
| Pubmed | CPEB2 FLNA DIP2A COPB1 SIPA1L1 CPEB4 MTMR1 PLCL1 PLEC DDB1 UNC13A VCP DNAH11 | 1.25e-05 | 1431 | 76 | 13 | 37142655 | |
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 1.41e-05 | 3 | 76 | 2 | 37343100 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 36050466 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23658173 | ||
| Pubmed | CPEB2, a novel putative translational regulator in mouse haploid germ cells. | 1.41e-05 | 3 | 76 | 2 | 12672660 | |
| Pubmed | Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. | 1.41e-05 | 3 | 76 | 2 | 21615408 | |
| Pubmed | Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction. | 1.41e-05 | 3 | 76 | 2 | 27228353 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 15961417 | ||
| Pubmed | Role of cardiac mitofusins in cardiac conduction following simulated ischemia-reperfusion. | 1.41e-05 | 3 | 76 | 2 | 36473917 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26446920 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 27713096 | ||
| Pubmed | DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression. | 1.41e-05 | 3 | 76 | 2 | 35178836 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31492966 | ||
| Pubmed | Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. | 1.41e-05 | 3 | 76 | 2 | 19477917 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34364121 | ||
| Pubmed | Mitochondrial fusion is required for regulation of mitochondrial DNA replication. | 1.41e-05 | 3 | 76 | 2 | 31170154 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34425738 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17236128 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 29787809 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 21245373 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17639022 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24513856 | ||
| Pubmed | Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. | 1.41e-05 | 3 | 76 | 2 | 18974884 | |
| Pubmed | Abrogating Mitochondrial Dynamics in Mouse Hearts Accelerates Mitochondrial Senescence. | 1.41e-05 | 3 | 76 | 2 | 29107503 | |
| Pubmed | Disruption of fusion results in mitochondrial heterogeneity and dysfunction. | 1.41e-05 | 3 | 76 | 2 | 15899901 | |
| Pubmed | Drp1 levels constitutively regulate mitochondrial dynamics and cell survival in cortical neurons. | 1.41e-05 | 3 | 76 | 2 | 19445933 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23427266 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19690333 | ||
| Pubmed | Mitochondrial fusion is required for spermatogonial differentiation and meiosis. | 1.41e-05 | 3 | 76 | 2 | 31596236 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20661427 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 33105896 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20855601 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 32846136 | ||
| Interaction | ITGB1 interactions | 2.23e-06 | 400 | 75 | 10 | int:ITGB1 | |
| GeneFamily | UNC13 homologs | 5.84e-05 | 4 | 57 | 2 | 836 | |
| GeneFamily | NLR family | 6.50e-05 | 25 | 57 | 3 | 666 | |
| GeneFamily | Dyneins, axonemal | 1.29e-03 | 17 | 57 | 2 | 536 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-07 | 153 | 75 | 6 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.12e-06 | 200 | 75 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.51e-06 | 150 | 75 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.25e-06 | 163 | 75 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.07e-05 | 172 | 75 | 5 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 177 | 75 | 5 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.52e-05 | 185 | 75 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-05 | 185 | 75 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-05 | 186 | 75 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.60e-05 | 187 | 75 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 187 | 75 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-05 | 188 | 75 | 5 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-05 | 188 | 75 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-05 | 189 | 75 | 5 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-05 | 192 | 75 | 5 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 192 | 75 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-05 | 195 | 75 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-05 | 195 | 75 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-05 | 197 | 75 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-05 | 197 | 75 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.06e-05 | 197 | 75 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-05 | 197 | 75 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Severe-B_intermediate-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.16e-05 | 199 | 75 | 5 | bf6ebb63ab361d9d1946225894d7be433e9befab | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.21e-05 | 200 | 75 | 5 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.21e-05 | 200 | 75 | 5 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.21e-05 | 200 | 75 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 200 | 75 | 5 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Fos_(Layer_5a,_IEG+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.20e-05 | 40 | 75 | 3 | b4c04100180790e1a53a15e8311e40015306c088 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 127 | 75 | 4 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.14e-04 | 148 | 75 | 4 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 148 | 75 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 153 | 75 | 4 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 154 | 75 | 4 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 154 | 75 | 4 | d0a1ff02a7e91f6923aa85b65094f78e357e377d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 159 | 75 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 159 | 75 | 4 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-04 | 159 | 75 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 160 | 75 | 4 | a494001b1f6dec33624f98fa3c24bad6988d0425 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 161 | 75 | 4 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 161 | 75 | 4 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.65e-04 | 163 | 75 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.65e-04 | 163 | 75 | 4 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.65e-04 | 163 | 75 | 4 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-04 | 164 | 75 | 4 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-04 | 166 | 75 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 168 | 75 | 4 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 168 | 75 | 4 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.90e-04 | 169 | 75 | 4 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-04 | 169 | 75 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-04 | 170 | 75 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.94e-04 | 170 | 75 | 4 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.94e-04 | 170 | 75 | 4 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.94e-04 | 170 | 75 | 4 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-04 | 173 | 75 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.07e-04 | 173 | 75 | 4 | 1e8a43ff32eab95857c794e0bf4f0b0dba155b4a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 174 | 75 | 4 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 174 | 75 | 4 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 174 | 75 | 4 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-04 | 175 | 75 | 4 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 175 | 75 | 4 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 175 | 75 | 4 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 176 | 75 | 4 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.21e-04 | 176 | 75 | 4 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 176 | 75 | 4 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.25e-04 | 70 | 75 | 3 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.26e-04 | 177 | 75 | 4 | 675003fbecee1b86919d1a6eeb268e1ca298f714 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.26e-04 | 177 | 75 | 4 | 72d144289167f200ac9f006d130de31e45568484 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 2.26e-04 | 177 | 75 | 4 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 178 | 75 | 4 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-04 | 179 | 75 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 179 | 75 | 4 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 180 | 75 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-04 | 180 | 75 | 4 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-04 | 180 | 75 | 4 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.41e-04 | 180 | 75 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.52e-04 | 182 | 75 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-04 | 182 | 75 | 4 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-04 | 183 | 75 | 4 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 183 | 75 | 4 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-04 | 183 | 75 | 4 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 183 | 75 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 184 | 75 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 184 | 75 | 4 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-04 | 184 | 75 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.62e-04 | 184 | 75 | 4 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 185 | 75 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.68e-04 | 185 | 75 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.68e-04 | 185 | 75 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 186 | 75 | 4 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 186 | 75 | 4 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-04 | 186 | 75 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 186 | 75 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 186 | 75 | 4 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.73e-04 | 186 | 75 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.73e-04 | 186 | 75 | 4 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| Drug | epirubicinol | 1.82e-06 | 8 | 74 | 3 | CID000128975 | |
| Drug | otavite | 1.04e-05 | 2 | 74 | 2 | CID000010564 | |
| Drug | mebeverine-alcohol | 1.04e-05 | 2 | 74 | 2 | CID000026649 | |
| Drug | 0JO | 1.04e-05 | 2 | 74 | 2 | CID015942668 | |
| Drug | Scaeg | 1.04e-05 | 2 | 74 | 2 | CID000063010 | |
| Disease | Charcot-Marie-Tooth disease type 2A2A (implicated_via_orthology) | 5.87e-06 | 2 | 72 | 2 | DOID:0110155 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 2A2B (implicated_via_orthology) | 5.87e-06 | 2 | 72 | 2 | DOID:0111557 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.72e-05 | 24 | 72 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | atrophic macular degeneration | 3.08e-05 | 25 | 72 | 3 | EFO_1001492 | |
| Disease | Charcot-Marie-Tooth disease type 2 (implicated_via_orthology) | 3.51e-05 | 4 | 72 | 2 | DOID:0050539 (implicated_via_orthology) | |
| Disease | Periventricular Nodular Heterotopia | 1.22e-04 | 7 | 72 | 2 | C1868720 | |
| Disease | mitochondrial DNA measurement | 1.52e-04 | 328 | 72 | 6 | EFO_0006312 | |
| Disease | primary pulmonary hypertension (is_marker_for) | 1.63e-04 | 8 | 72 | 2 | DOID:14557 (is_marker_for) | |
| Disease | Colorectal Carcinoma | 3.09e-04 | 702 | 72 | 8 | C0009402 | |
| Disease | Paranoia | 3.18e-04 | 11 | 72 | 2 | C1456784 | |
| Disease | Autistic Disorder | 4.50e-04 | 261 | 72 | 5 | C0004352 | |
| Disease | smoking status measurement | OMA1 DPP10 PTPRN2 PRELID2 SETBP1 CPEB4 PLCL1 CADPS2 DNAH8 ICA1L | 4.97e-04 | 1160 | 72 | 10 | EFO_0006527 |
| Disease | coronary artery disease | 6.22e-04 | 1194 | 72 | 10 | EFO_0001645 | |
| Disease | mean reticulocyte volume | 7.25e-04 | 799 | 72 | 8 | EFO_0010701 | |
| Disease | mean platelet volume | 8.22e-04 | 1020 | 72 | 9 | EFO_0004584 | |
| Disease | Age-related macular degeneration | 8.76e-04 | 18 | 72 | 2 | cv:C0242383 | |
| Disease | body weight | SECISBP2L UNC13B IPO9 COPB1 GUSB SETBP1 CPEB4 ST3GAL1 PLCL1 CADPS2 | 9.44e-04 | 1261 | 72 | 10 | EFO_0004338 |
| Disease | neuroimaging measurement | 1.14e-03 | 1069 | 72 | 9 | EFO_0004346 | |
| Disease | red blood cell density measurement | 1.35e-03 | 880 | 72 | 8 | EFO_0007978 | |
| Disease | Ischemic stroke, coronary artery disease | 1.50e-03 | 92 | 72 | 3 | EFO_0001645, HP_0002140 | |
| Disease | mosquito bite reaction size measurement | 1.82e-03 | 212 | 72 | 4 | EFO_0008378 | |
| Disease | electrocardiography | 1.87e-03 | 530 | 72 | 6 | EFO_0004327 | |
| Disease | macular degeneration (is_implicated_in) | 1.98e-03 | 27 | 72 | 2 | DOID:4448 (is_implicated_in) | |
| Disease | Weight Gain | 2.01e-03 | 102 | 72 | 3 | C0043094 | |
| Disease | sodium measurement | 2.07e-03 | 103 | 72 | 3 | EFO_0009282 | |
| Disease | S-6-hydroxywarfarin measurement | 2.07e-03 | 368 | 72 | 5 | EFO_0803326 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 2.28e-03 | 29 | 72 | 2 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 2.28e-03 | 29 | 72 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 2.28e-03 | 29 | 72 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 2.28e-03 | 29 | 72 | 2 | C3658302 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQPSWEQDFMFEINR | 41 | Q9UPW8 | |
| ASAFEPMNEWERNLA | 951 | Q13075 | |
| PRESQADDMANFDWR | 486 | P78363 | |
| QEDQFPSADVRTWAM | 676 | P33076 | |
| AAWNNEGLPSDRMST | 3466 | Q96DT5 | |
| SPQFTQTDAMDHRRW | 376 | Q8N7E2 | |
| WNPMEAFIFTAANED | 246 | Q9NV06 | |
| EMTSDTWLSQQNEEP | 361 | Q8N608 | |
| DCVWQMTRQFPSAFE | 506 | Q13613 | |
| SDWNPTVDQQAMDRA | 1196 | Q9ULG1 | |
| NEDLRSWTAADMAAQ | 151 | P01893 | |
| ASSWSEEPVQSNMDI | 711 | Q92932 | |
| NNRWDASASEPEYME | 236 | Q8IWA4 | |
| FSRFWAQREMEDSQP | 336 | Q5T5X7 | |
| SQSDPETKDFWLNMA | 701 | O14526 | |
| LADFNSSWRDAMVQD | 141 | Q9UBM8 | |
| PSSRWESFWMNRENE | 186 | Q9HBG6 | |
| ASSVNWNSANPDDMV | 41 | Q9ULD2 | |
| DNSVTVAWRMPEEDN | 211 | Q9BXM9 | |
| GNMSANASDQERTPW | 466 | P06681 | |
| FTVSSNEMSWVRQAP | 46 | P0DTE1 | |
| SSSEQSLTEMWRPNN | 1266 | Q15652 | |
| DPRNTDNAWMETEAV | 271 | Q9BW91 | |
| QPATCTDAEFRQMWA | 831 | P53618 | |
| QENRSSAAAMWPGTD | 126 | Q9Y6X5 | |
| QMFGRLDTATNDWTD | 2166 | Q96JB1 | |
| TNSAQRWIEAMEDAS | 1446 | Q6ZNL6 | |
| SSPATEQSWMENDFD | 26 | Q9UN81 | |
| NKATDPSMSEQDWSA | 31 | Q9UJY4 | |
| PSMSEQDWSAIQNFC | 36 | Q9UJY4 | |
| RSFENTAADWPEMQT | 251 | P59047 | |
| IAENMWDPFSTTQTS | 691 | Q9Y5B6 | |
| LNNRWDASASEPEYM | 256 | O95140 | |
| NWYSDADMPASARQE | 186 | P09923 | |
| FRFPADAEWALNTMN | 66 | Q96DU9 | |
| WNLSDSDFVMDGSQP | 421 | Q7Z5Q1 | |
| PVTNAREAMQQADDW | 221 | P21333 | |
| IWNFADFMTEQSPTR | 586 | P08236 | |
| QRPDSTEEDSFQWMS | 846 | Q9Y2E4 | |
| DMDTALEAQPQDSWD | 886 | Q86UW7 | |
| EMSASDTRQRQEWTA | 291 | Q9H4E7 | |
| NEDLRSWTAADMAAQ | 151 | P04439 | |
| SMEWNRWPNVDSETT | 96 | Q9UH90 | |
| QATPAEWSQDDSNDM | 936 | Q96P70 | |
| APKSWMEDSLNRADN | 356 | Q17RY0 | |
| WNLSDSDFVMDGSQP | 561 | Q17RY0 | |
| RGNTWDERDDSPNTM | 616 | Q9NRM1 | |
| QRPDASEEDSFQWMS | 861 | Q14689 | |
| SEEDSFQWMSRVLQA | 866 | Q14689 | |
| QDMSAWFNLFADLDP | 451 | Q8NDH6 | |
| NFEEIARDFNPNWMS | 941 | Q16531 | |
| PNWMSAVEILDDDNF | 951 | Q16531 | |
| WLQEQMSASSSREPS | 331 | P0CW18 | |
| SFHANDTRWAAAAMP | 201 | Q5XKR4 | |
| DLMDSFNESNSRISW | 51 | O15403 | |
| NNRDDSLDWFDFMAT | 736 | Q9NXL9 | |
| SSQNDVDMSWIPQET | 246 | P43307 | |
| RSSFESPAQDQSWMF | 2621 | Q8WUY3 | |
| WNFEQISFPNMASDS | 296 | Q7Z6J9 | |
| TPSWQRSEDSIADQM | 1201 | O43166 | |
| SAWFDERFNQTMQPL | 71 | Q11201 | |
| PGMDSEAWTADQQAS | 1061 | Q93073 | |
| QDPASWNETFAEMSR | 1566 | P14410 | |
| RASSVFWQQMEFVDS | 411 | Q96E52 | |
| TMRDSSNPRQNWNDV | 181 | Q9ULY5 | |
| SEEDLSEATWMEQPN | 256 | Q5M9Q1 | |
| AMRIDSSNLNPQDFW | 646 | Q15111 | |
| AVTMDDFRWALSQSN | 446 | P55072 | |
| SWVVSDAPTEDDMAN | 201 | Q8WVD5 | |
| MFQTAWRQEPVTFED | 1 | Q6ZNG0 | |
| VEADPANMFNWTTEE | 36 | Q9BY14 | |
| KEESVFRESMENPNW | 121 | Q8N945 | |
| FRESMENPNWTEFIQ | 126 | Q8N945 | |
| DQPSWEQDFMFEISR | 41 | O14795 | |
| NDVDDFNWLARDMAS | 316 | Q15814 | |
| ASQAAQDEMWTAVRA | 51 | Q147U7 | |
| EVGFDWSDRNTNMTA | 776 | Q15149 | |
| MAQVDSQDRWGEASP | 1 | Q5T619 | |
| SSWVQDGSPEMAENE | 536 | Q96DT7 | |
| LFQNDFWGTPMSEER | 51 | Q6ZXV5 | |
| FSEMNPSNDKWDSDV | 1281 | Q9Y6X0 | |
| EATLNDPQWSRMFMS | 1576 | Q9Y4A5 |